MRK

Merck & Co., Inc.

Healthcare
127.50 down -0.13 -0.10% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 314.90B
EV 358.32B
Shares Out 2.47B
Revenue (ttm) 65.77B
Net Income 8.94B
Beta
P/E
Forward P/E
EPS (ttm) $3.55
P/S 4.79
P/B 6.87
P/FCF 22.33
P/C 17.62
EV/Sales 5.45
EV/EBITDA
ROA 6.94%
ROE 18.82%
ROIC
Gross Margin
Oper. Margin
Profit Margin 13.59%
Debt/Eq 1.07
LT Debt/Cap 50.43%
Quick Ratio 0.66
Current Ratio 1.30
Book/sh 18.56
Cash/sh 2.15
Div Yield 2.6%
Div TTM $3.32
Payout Ratio 93.52%
SMA20 2.4%
SMA50 6.67%
SMA200 16.44%
Volume 10,695,310
Avg Volume 10.15M
Rel Volume 1.05
Perf Week 2.80%
Perf Month 11.97%
Perf Quarter 8.88%
Perf Half Y 16.49%
Perf YTD 21.13%
Perf Year 59.45%
Perf 3Y 17.55%
Perf 5Y 67.39%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8500
TTM Yield 2.60%
TTM Amount $3.32
Payout Ratio 93.52%
3-Yr Growth (CAGR) 5.42%
5-Yr Growth (CAGR) 5.75%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.8500
Q4 2025 ~2025-12-30 $0.8500
Q3 2025 ~2025-09-30 $0.8100
Q2 2025 ~2025-06-30 $0.8100
Q1 2025 ~2025-03-31 $0.8100
Q4 2024 ~2024-12-30 $0.8100
Q3 2024 ~2024-09-30 $0.7700
Q2 2024 ~2024-06-30 $0.7700
Q1 2024 ~2024-03-31 $0.7700
Q4 2023 ~2023-12-30 $0.7700
Q3 2023 ~2023-09-30 $0.7300
Q2 2023 ~2023-06-30 $0.7300

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Merck & Co., Inc. is a leading global healthcare company engaged in the business of discovering, developing, producing and marketing a broad range of human and animal health

Name
Merck & Co., Inc.
Industry
Drug Manufacturers - General
CEO
Robert M. Davis · Chairman, Chief Executive Officer and President
Employees
IPO Date
2018-03-01
Phone
908-740-4000
Address
126 East Lincoln Avenue, Rahway, NJ 07065
Website
www.merck.com

Key Executives

Name Title FY Pay
Jennifer Zachary Executive Vice President and General Counsel
Dean Li, M.D., Ph.D. Executive Vice President and President, Merck Research Laboratories
Sanat Chattopadhyay Executive Vice President and President, Merck Manufacturing Division
Caroline Litchfield Executive Vice President and Chief Financial Officer
Robert M. Davis Chairman, Chief Executive Officer and President

Latest News